SYMVIVO CORPORATION
Symvivo Corporation is a platform that delivers plasmid DNA, both orally and through IV administration, that enables a patient’s own cells to produce biologics. They make therapeutic developments in the fields of oral vaccines, cancer, immunology, and biologics. Symvivo Corporation is creating the next generation of vaccines by offering orally delivered, room-temperature stable medicines that can generate both systemic and mucosal immunity, as well as scalable and cost-effective manufacturing procedures.
SYMVIVO CORPORATION
Industry:
Biotechnology Health Care Health Diagnostics Medical
Founded:
2013-01-01
Address:
Burnaby, British Columbia, Canada
Country:
Canada
Website Url:
http://www.symvivo.com
Total Employee:
11+
Status:
Active
Total Funding:
650 K USD
Technology used in webpage:
IPhone / Mobile Compatible Viewport Meta SPF Google Tag Manager Google Analytics Content Delivery Network LetsEncrypt SSL By Default Global Site Tag HSTS
Similar Organizations
Alzamend Neuro
Alzamend Neuro is an innovative biotechnology company that develops and commercializes drugs, treatments, and cures for Alzheimer's disease.
Artiam Bio
Artiam Bio is a biotechnology focused on the development of second-generation type 1 cannabinoid receptor antagonists for the treatment.
HiberCell
HiberCell is a biotechnology company developing treatments to prevent cancer relapse and metastasis.
Juventas Therapeutics
Juventas Therapeutics is a clinical-stage biotechnology company developing regenerative therapies to treat life threatening diseases.
Soligenix
Soligenix is a biopharmaceutical company that develops biodefense vaccines and therapeutics to treat rare diseases.
T2 Biosystems
T2 Biosystems is a biotechnology company that develops diagnostic products for rapid and accurate detection of various diseases.
Tome Biosciences
Tome Biosciences is a biotechnology company that develops programmable gene insertion technology.
TruDiagnostic
TruDiagnostic is a biodata research company that offers epigenetic testing and research services.
Zura Bio
Zura Bio is a clinical-stage biotechnology company that develops medicines for immune system disorders.
Current Advisors List
Advisor
2018-04-01
Current Employees Featured
Alexander Graves CEO and Founder @ Symvivo Corporation
CEO and Founder
2013-04-01
Founder
Investors List
Pacific Economic Development Canada
Pacific Economic Development Canada investment in Grant - Symvivo Corporation
Official Site Inspections
http://www.symvivo.com
- Host name: 198.185.159.145
- IP address: 198.185.159.145
- Location: New York United States
- Latitude: 40.7157
- Longitude: -74
- Metro Code: 501
- Timezone: America/New_York
- Postal: 10013
More informations about "Symvivo Corporation"
Symvivo Corporation - Crunchbase Company Profile
Symvivo Corporation is a platform that delivers plasmid DNA, both orally and through IV administration, that enables a patient’s own cells to produce biologics. They make therapeutic developments in the fields of oral vaccines, cancer, …See details»
Symvivo Corporation - LinkedIn
Symvivo is a clinical-stage biotechnology company advancing a proprietary platform for the site-specific delivery of genes for the treatment and prevention of life-threatening diseases.See details»
Symvivo Corporation Information - RocketReach
Symvivo is a clinical-stage biotechnology company advancing a proprietary platform for the site-specific delivery of genes for the treatment and prevention of life-threatening diseases. …See details»
Symvivo Corporation Company Profile - Dun & Bradstreet
Find company research, competitor information, contact details & financial data for Symvivo Corporation of Burnaby, BC. Get the latest business insights from Dun & Bradstreet.See details»
Symvivo Company Profile 2025: Valuation, Funding & Investors
When was Symvivo founded? Symvivo was founded in 2013. Where is Symvivo headquartered? Symvivo is headquartered in Burnaby, Canada. What is the size of Symvivo? Symvivo has 13 …See details»
Symvivo Corporation - The Org
Symvivo Corporation is a clinical-stage biotechnology company that develops DNA vaccines for genetic and life-threatening diseases. Industries. Biotechnology, Health Care +1. …See details»
Symvivo Corporation Overview | SignalHire Company Profile
The position of the Founder & CEO is occupied by Alexander Graves. Its headquarters is located at Burnaby, British Columbia, CA. The Symvivo Corporation annual revenue is estimated at < …See details»
Symvivo Corporation - Contacts, Employees, Board Members
Organization. Symvivo Corporation . Connect to CRM . Save . Summary. Financials. People. Technology. Signals & News. ... Contacts 17. About. Symvivo Corporation has 1 current …See details»
Symvivo - Overview, News & Similar companies | ZoomInfo.com
Jan 4, 2021 Symvivo contact info: Phone number: (604) 428-7474 Website: www.symvivo.com What does Symvivo do? Symvivo, founded in 2013 and headquartered in Burnaby, Canada, is …See details»
Symvivo Corporation - Funding, Financials, Valuation & Investors
Symvivo Corporation is a clinical-stage biotechnology company that develops DNA vaccines for genetic and life-threatening diseases. Search Crunchbase. ... How much funding has this …See details»
Symvivo Corporation :: Canada :: OpenCorporates
Symvivo Corporation Company Number 8468184 Status Active Incorporation Date 21 March 2013 (over 9 years ago) Company Type Non-distributing corporation with 50 or fewer shareholders …See details»
Symvivo - Products, Competitors, Financials, Employees, …
Symvivo. Frequently Asked Questions (FAQ) When was Symvivo founded? Symvivo was founded in 2013. Where is Symvivo's headquarters? Symvivo's headquarters is located at 102 – 4475 …See details»
Symvivo - VentureRadar
Symvivo has invented and patented a novel protein based mechanism that enables probiotic bacteria to consistently produce and deliver therapeutic plasmid DNA to colonized tissues. …See details»
Symvivo Company Profile - Office Locations, Competitors ... - Craft
Symvivo is a biotechnology company that specializes in the cancer gene therapy field. It develops bacTRL, a live cell probiotic-based gene delivery platform designed for the treatment of solid …See details»
Symvivo Corporation receives funding for COVID-19 Vaccine
Jul 19, 2021 Symvivo is advancing therapeutics in the area of oral DNA vaccines, oncology and biologics. ... Organization Profile. Symvivo. Contact Cision. 866-245-2317 from 8 AM - 10 PM ETSee details»
Symvivo - whiteroseintelligence.com
Symvivo Corporation is a Canadian biotechnology company based in Burnaby, British Columbia. Activities The COVID-19 Vaccine Task Force considered a proposal from Symvivo on June …See details»
Symvivo Corporation - Tech Stack, Apps, Patents & Trademarks
Symvivo Corporation uses 14 technology products and services including HTML5, Lightbox, and Office 365, according to G2 Stack. Symvivo Corporation is actively using 10 technologies for …See details»
Symvivo Corporation Announces Research Collaboration With …
November 24, 2020 – BURNABY, British Columbia — Symvivo Corporation, a clinical-stage biotechnology company advancing a proprietary bacTRL™ gene delivery platform, announced …See details»
Symvivo | Biotech Careers
Symvivo has invented and patented a novel protein based mechanism that enables probiotic bacteria to consistently produce and deliver therapeutic plasmid DNA to colonized tissues. …See details»
Symvivo Corp. (Symvivo Corp.) - 药物管线_专利_临床试验_投融营 …
About Symvivo Symvivo is a clinical-stage biotechnology company advancing a proprietary platform for the site-specific delivery of genes for the treatment and prevention of life …See details»